Intramuscular injection typically produces sharper pain during injection, more soreness for 24 to 48 hours afterward, and sometimes a small bruise
Novo Nordisk received FDA approval for its semaglutide-based GLP-1 products, Ozempic for diabetes and Wegovy for weight loss, in December 2017 and June 2021, respectively
Mazdutide (IBI362 or LY3305677) is a once-weekly oxyntomodulin analogue which acts both on GLP-1 and glucagon receptors [65]
Emerging evidence indicates their potential role in the management of diverse obesity-related comorbidities, including metabolic dysfunction-associated steatotic liver disease, obstructive sleep apnea, polycystic ovary syndrome, neurodegenerative disorders, and even substance use disorders
If you are noticing an effect on your mood while using a GLP-1 medication, heres what might be at play
Competitive Landscape Leading GLP-1 receptor agonist companies focus on R&D, clinical trials, and staff training, while collaborating with hospitals and research centers